Vitaminspice Inc.; Order of Suspension of Trading, 12127 [2013-04083]

Download as PDF Federal Register / Vol. 78, No. 35 / Thursday, February 21, 2013 / Notices amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549, on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of such filings also will be available for inspection and copying at the principal office of ICE Clear Credit and on ICE Clear Credit’s Web site at https:// www.theice.com/publicdocs/ regulatory_filings/ ICEClearCredit_20130131.pdf. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–ICC–2013–01 and should be submitted on or before March 14, 2013. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.5 Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2013–03971 Filed 2–20–13; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–68929; File No. SR–CME– 2012–34] Self-Regulatory Organizations; Chicago Mercantile Exchange Inc.; Notice of Designation of a Longer Period for Commission Action on Proposed Rule Change Related to the Liquidity Factor of CME’s CDS Margin Methodology erowe on DSK2VPTVN1PROD with NOTICES February 14, 2013. 5 17 CFR 200.30–3(a)(12). U.S.C. 78s(b)(1). 2 17 CFR 240.19b–4. 1 15 14:47 Feb 20, 2013 For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.6 Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2013–03967 Filed 2–20–13; 8:45 am] On December 10, 2012, Chicago Mercantile Exchange Inc. (‘‘CME’’) filed with the Securities and Exchange Commission (‘‘Commission’’), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 a proposed rule change to make adjustments to the liquidity risk factor component of its VerDate Mar<15>2010 credit default swap (‘‘CDS’’) margin model. CME proposes to use an index portfolio’s market risk rather than its gross notional as the basis for determining the margins associated with the liquidity risk factor component. The proposed rule change was published for comment in the Federal Register on December 31, 2012.3 The Commission did not receive comments on the proposal. Section 19(b)(2) of the Act 4 provides that within 45 days of the publication of notice of the filing of a proposed rule change, or within such longer period up to 90 days as the Commission may designate if it finds such longer period to be appropriate and publishes its reasons for so finding or as to which the self-regulatory organization consents, the Commission shall either approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether the proposed rule change should be disapproved. The 45th day from the publication of notice of filing of this proposed rule change is February 14, 2013. The Commission is extending this 45-day time period. The Commission finds it is appropriate to designate a longer period within which to take action on the proposed rule change so that it has sufficient time to consider the proposed rule change, which would implement a significant change to CME’s CDS margin methodology. Accordingly, the Commission, pursuant to Section 19(b)(2) of the Act,5 designates March 31, 2013, as the date by which the Commission should either approve or disapprove, or institute proceedings to determine whether to disapprove, the proposed rule change (File No. SR–CME–2012–34). Jkt 229001 BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] Vitaminspice Inc.; Order of Suspension of Trading February 19, 2013. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of VitaminSpice Inc. (‘‘VitaminSpice’’) because of questions regarding the adequacy of current financial information available about VitaminSpice; and the accuracy of assertions by VitaminSpice, and by others, in press releases to investors, in periodic financial filings and in internet promotions concerning, among other things, the company’s revenues and operations. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST, on February 19, 2013 through 11:59 p.m. EST, on March 4, 2013. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2013–04083 Filed 2–19–13; 11:15 am] BILLING CODE 8011–01–P SOCIAL SECURITY ADMINISTRATION [Docket No. SSA 2013–0007] Privacy Act of 1974, as Amended; Computer Matching Program (SSA/ Department of the Treasury, Internal Revenue Service (IRS))—Match Number 1310 AGENCY: Social Security Administration (SSA). Notice of a renewal of an existing computer matching program that will expire March 31, 2013. ACTION: In accordance with the provisions of the Privacy Act, as amended, this notice announces a renewal of an existing computer matching program that we are currently conducting with IRS. DATES: We will file a report of the subject matching program with the Committee on Homeland Security and Governmental Affairs of the Senate; the SUMMARY: 3 Securities Exchange Act Release No. 68529 (December 21, 2012), 77 FR 77160 (December 31, 2012). 4 15 U.S.C. 78s(b)(2). 5 15 U.S.C. 78s(b)(2). 6 17 CFR 200.30–3(a)(31). PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 12127 E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)]
[Notices]
[Page 12127]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04083]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Vitaminspice Inc.; Order of Suspension of Trading

February 19, 2013.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
VitaminSpice Inc. (``VitaminSpice'') because of questions regarding the 
adequacy of current financial information available about VitaminSpice; 
and the accuracy of assertions by VitaminSpice, and by others, in press 
releases to investors, in periodic financial filings and in internet 
promotions concerning, among other things, the company's revenues and 
operations.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed company is suspended for the period from 9:30 a.m. EST, on 
February 19, 2013 through 11:59 p.m. EST, on March 4, 2013.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2013-04083 Filed 2-19-13; 11:15 am]
BILLING CODE 8011-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.